Antibody Binding Simulator: Affinity, Avidity & Immune Complex Formation

simulator intermediate ~10 min
Loading simulation...
θ = 83.3% — antigen binding saturation

At 50 nM antibody with Kd = 10 nM, 83% of antigen epitopes are occupied. Bivalent binding (IgG) further strengthens the effective interaction through avidity effects.

Formula

θ = [Ab] / (Kd + [Ab]) (Langmuir binding isotherm)
Kd = k_off / k_on (dissociation constant)
[AbAg] = [Ab]_total × [Ag] / (Kd + [Ag])

Lock and Key Recognition

Antibodies recognize antigens through complementary molecular surfaces — the paratope on the antibody fits the epitope on the antigen like a lock and key. This interaction involves hydrogen bonds, van der Waals forces, electrostatic attractions, and hydrophobic packing across a contact area of roughly 600-900 square angstroms. The cumulative strength of these noncovalent interactions determines the binding affinity, quantified by the dissociation constant Kd.

Affinity vs. Avidity

A single antibody binding site may have modest affinity, but antibodies are multivalent: IgG has two identical binding sites, while IgM assembles into a pentamer with ten. When multiple sites engage a multivalent antigen simultaneously, the effective binding strength (avidity) increases dramatically — dissociation requires all sites to release simultaneously, which is exponentially less likely. This is why early IgM antibodies, despite lower affinity per site, effectively neutralize pathogens.

Binding Equilibrium

At equilibrium, the fraction of bound antigen follows the Langmuir isotherm: saturation increases with antibody concentration and decreases with Kd. When antibody concentration equals Kd, exactly half the epitopes are occupied. This simple relationship underlies ELISA assays, therapeutic antibody dosing calculations, and vaccine efficacy predictions. The simulation shows how shifting each parameter changes the binding curve in real time.

From Binding to Protection

Antibody binding translates to immune protection through multiple mechanisms. Neutralization physically blocks pathogen receptor binding. Opsonization coats pathogens with antibody tags that phagocytes recognize. Complement activation triggers a destructive cascade on antibody-coated surfaces. The required binding saturation for each mechanism differs — neutralization may need only a few bound antibodies, while complement requires dense coating, explaining why different Kd thresholds matter clinically.

FAQ

What determines antibody binding strength?

Antibody binding strength has two components: affinity (the strength of a single binding site interaction, measured by Kd) and avidity (the combined strength of all binding sites). IgG has two binding sites, while IgM has ten. Avidity can make a low-affinity antibody functionally potent through multivalent binding.

What is the dissociation constant Kd?

Kd is the antigen concentration at which half the antibody binding sites are occupied at equilibrium. Lower Kd means higher affinity. Therapeutic antibodies typically have Kd values in the picomolar to low nanomolar range (0.01-10 nM), while natural antibodies range from nanomolar to micromolar.

How do antibodies neutralize pathogens?

Antibodies neutralize pathogens by blocking receptor binding sites (preventing cell entry), opsonizing surfaces for phagocyte recognition, activating complement cascade for lysis, and cross-linking antigens into immune complexes cleared by the reticuloendothelial system.

What is affinity maturation?

Affinity maturation is the process by which B-cells in germinal centers undergo somatic hypermutation — random mutations in antibody genes — followed by selection for higher antigen affinity. Over weeks, this Darwinian process can improve antibody Kd by 100-1000 fold, producing highly specific, high-affinity antibodies.

Sources

Embed

<iframe src="https://homo-deus.com/lab/immunology/antibody-binding/embed" width="100%" height="400" frameborder="0"></iframe>
View source on GitHub